Emergent BioSolutions Inc. — Director's Dealing 2018

Jan 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-01-22

Reporting Person: Hauer Jerome M (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-22	Common Stock	M	5152	$25.47	Acquired	23797	Direct
2018-01-22	Common Stock	S	5152	$50.9108	Disposed	18645	Direct
2018-01-23	Common Stock	S	2577	$50.25	Disposed	16068	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-22	Stock Option (Right to Buy)	$25.47	M	5152	Disposed	2022-01-21	Common Stock (5152)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Hauer.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.25 to $51.25, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F3: Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.

F4: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.